Latest article
The world’s first-in-class miRNA therapeutics to treatment diabetes by pancreatic beta cell regeneration
While RNA vaccine development has been in the spotlight since the Corona-19 outbreak, RSVI-301, RosVivo’s new drug pipeline for diabetes, also uses miRNA (micro-RNA)....
Tandem Diabetes Care Proclaims First Quarter 2021 Monetary Outcomes and Up to date Full...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company,...
